The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.
Continue ReadingThere are more exciting opportunities than ever before to participate in celiac disease clinical trials. Researchers are making groundbreaking progress in the race for better treatments with promising new drug candidates.
Continue ReadingThank you to Provention Bio, Inc., for supporting our upcoming Patient Education and Advocacy Summit. Provention Bio, Inc., is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. Register now to be a part of this monumental event!
Continue ReadingDietitians and doctors say a new federal bill to extend Medicare coverage for nutritional therapy provided by a registered dietitian would provide better healthcare for Americans with celiac disease.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...